🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A number of studies suggest that the combination of PARP inhibitors and ant...
Status
Completed
Location
Sun Yat-sen University Cancer Cetntre
Start Date
2022-09-22
Trial ID
NCT05494580
Treatments Being Tested
This study enrolled participants with previously-treated advanced or inoper...
Status
Completed
Location
Miami Cancer Institute
Start Date
2018-07-03
Trial ID
NCT03427814
This study is designed to evaluate the safety, tolerability, PKharmacokinet...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2016-12-21
Trial ID
NCT03333915
Treatments Being Tested
The study was an open-label, parallel-group, fixed-sequence study in male a...
Status
Completed
Location
Arensia Exploratory Medicine Llc
Start Date
2019-05-29
Trial ID
NCT03994211
Treatments Being Tested
The goal of this phase II single arm prospective clinical study is to evalu...
Status
Unknown
Location
Sun Yat-sen University Cancer Centre
Start Date
2023-01-01
Trial ID
NCT05669768
Treatments Being Tested
This is an open-label, multicenter, extension study to evaluate the long-te...
Status
Completed
Location
Mount Sinai Medical Center Braman Comprehensive Cancer Center
Start Date
2019-12-19
Trial ID
NCT04164199
This phase I/II trial studies the side effects and how well BGB-290 and tem...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2020-02-16
Trial ID
NCT03914742
Treatments Being Tested
To evaluate the pathological response rate of pamiparib combined with abira...
Status
Unknown
Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Start Date
2022-02-22
Trial ID
NCT05376722
Treatments Being Tested
The study contains Phase 1A and Phase 1B. Phase 1A has Part1 (BID Dose Esca...
Status
Completed
Location
Gosford Hospital
Start Date
2014-07-03
Trial ID
NCT02361723
The main objective of this trial is to evaluate the activity of pamiparib p...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05
Trial ID
NCT04796454
Treatments Being Tested